Leila Pirhaji ^UDM

Leila Pirhaji is an expert in the intersection of Artificial Intelligence (AI) and Biology with a Ph.D. from MIT. She is the Founder and CEO of ReviveMed, an award-winning AI-based metabolomic platform for precision medicine. ReviveMed, an MIT spinout, focuses on metabolites, small molecules crucial for understanding diseases, patient physiology, and immune system activity. The platform developed by ReviveMed, with advanced AI models, identifies more than 10,000 metabolite signals per patient, facilitating novel biological discoveries. The company Partnerss with pharma companies for target discovery, patient stratification, and clinical trial optimization, while also concentrating on internal programs focused on immune-metabolic disorders.